AFT Pharmaceuticals Ltd.'s market cap is currently ―. The company's EPS TTM is AU$0.096; its P/E ratio is 29.47; and it has a dividend yield of 0.35%. AFT Pharmaceuticals Ltd. is scheduled to report earnings on May 22, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 22	Mar 21	Mar 20	Mar 19
Income Statement	-
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
EBIT	-	-	-	-
EBITDA	-	-	-	-
Net Income Common Stockholders	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 7.94M	$ 3.21M	$ 5.97M	$ 6.62M
Total Assets	$ 121.76M	$ 105.13M	$ 84.87M	$ 60.90M
Total Debt	$ 40.51M	$ 42.22M	$ 46.02M	$ 39.98M
Net Debt	$ 32.57M	$ 39.01M	$ 40.05M	$ 33.36M
Total Liabilities	$ 65.02M	$ 68.54M	$ 68.05M	$ 56.03M
Stockholders Equity	$ 56.74M	$ 36.59M	$ 16.82M	$ 4.88M
Cash Flow	-
Free Cash Flow	-	-	-	-
Operating Cash Flow	-	-	-	-
Investing Cash Flow	-	-	-	-
Financing Cash Flow	-	-	-	-

Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

AFT Pharmaceuticals Ltd. Debt to Assets

Balance Sheet >

AFT Pharmaceuticals Ltd. Cash Flow

Cash Flow >

AFT Pharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing